» Articles » PMID: 30777112

Community Perspectives on Treating Asymptomatic Infections for Malaria Elimination in The Gambia

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2019 Feb 20
PMID 30777112
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Innovative and cost-effective strategies that clear asymptomatic malaria infections are required to reach malaria elimination goals, but remain a challenge. This mixed methods study explored people's attitudes towards the reactive treatment of compound contacts of malaria cases with a 3-day course of dihydroartemisinin-piperaquine (DHAP), the socio-cultural representations of asymptomatic infections, and more specifically their treatment.

Methods: Prior to the start of the intervention, a sequential mixed method study was carried out. Qualitative data collection involved in-depth interviews and participant observations (including informal conversations) with key informants from the trial communities and the trial staff. Quantitative data were derived from a pre-trial cross-sectional survey on health literacy and health-seeking behaviour among randomly selected members of the study communities.

Results: In the pre-trial cross-sectional survey, 73% of respondents reported that malaria could be hidden in the body without symptoms. Whilst this may be interpreted as people's comprehension of asymptomatic malaria, qualitative data indicated that informants had different interpretations of asymptomatic disease than the biomedical model. It was described as: (i) a minor illness that does not prevent people carrying out daily activities; (ii) an illness that oscillates between symptomatic and asymptomatic phases; and, (iii) a condition where disease agents are present in the body but remain hidden, without signs and symptoms, until something triggers their manifestation. Furthermore, this form of hidden malaria was reported to be most present in those living in the same compound with a malaria case (71%).

Conclusion: Treating asymptomatic malaria with pharmaceuticals was considered acceptable. However, people felt uncertain to take treatment without screening for malaria first, largely due to the lack of symptoms. Knowledge of asymptomatic malaria was not a strong re-inforcement for treatment adherence. In this study, the pre-intervention active engagement of communities existed of having people co-design accurate information messages about their personal risk of malaria, which increased their trust in expert knowledge and thus proved essential for the successful implementation of the community-based intervention.

Citing Articles

Diagnostic performance of an ultra-sensitive RDT and a conventional RDT in malaria mass testing, treatment and tracking interventions in southern Ghana.

Amoah L, Cheng N, Acquah F, Adu-Amankwah S, Bredu D, Mensah B Parasit Vectors. 2024; 17(1):280.

PMID: 38951912 PMC: 11218287. DOI: 10.1186/s13071-024-06354-x.


Reactive Case Detection and Treatment and Reactive Drug Administration for Reducing Malaria Transmission: A Systematic Review and Meta-Analysis.

Steinhardt L, Kc A, Tiffany A, Quincer E, Loerinc L, Laramee N Am J Trop Med Hyg. 2023; 110(4_Suppl):82-93.

PMID: 38118166 PMC: 10993791. DOI: 10.4269/ajtmh.22-0720.


Knowledge about Asymptomatic Malaria and Acceptability of Using Tea among Health Care Workers (HCWs) in Yaoundé, Cameroon: A Cross-Sectional Survey.

Suh Nchang A, Shinyuy L, Noukimi S, Njong S, Bambara S, Kalimba E Int J Environ Res Public Health. 2023; 20(13).

PMID: 37444156 PMC: 10341543. DOI: 10.3390/ijerph20136309.


Acceptability and perceived barriers to reactive focal mass drug administration in the context of a malaria elimination program in Magude district, Southern Mozambique: A qualitative study.

Cuinhane C, Galatas B, Lopez J, Djive H, Nhantumbo H, Murato I PLoS One. 2023; 18(3):e0283160.

PMID: 37000890 PMC: 10065238. DOI: 10.1371/journal.pone.0283160.


A Comparative Study of Asymptomatic Malaria in a Forest Rural and Depleted Forest Urban Setting during a Low Malaria Transmission and COVID-19 Pandemic Period.

Mbah C, Ambe L, Ngwewondo A, Kidzeru E, Akwah L, Mountchissi C Biomed Res Int. 2022; 2022:2545830.

PMID: 36281461 PMC: 9587908. DOI: 10.1155/2022/2545830.


References
1.
Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L . Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015; 93(1):125-134. PMC: 4497884. DOI: 10.4269/ajtmh.14-0254. View

2.
Ventura-Garcia L, Roura M, Pell C, Posada E, Gascon J, Aldasoro E . Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis. 2013; 7(9):e2410. PMC: 3772024. DOI: 10.1371/journal.pntd.0002410. View

3.
Baum E, Sattabongkot J, Sirichaisinthop J, Kiattibutr K, Jain A, Taghavian O . Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination. Malar J. 2016; 15:333. PMC: 4918199. DOI: 10.1186/s12936-016-1393-4. View

4.
Schellenberg J, Smith T, Alonso P, Hayes R . What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today. 1994; 10(11):439-42. DOI: 10.1016/0169-4758(94)90179-1. View

5.
Muela Ribera J, Hausmann-Muela S, Gryseels C, Peeters Grietens K . Re-imagining adherence to treatment from the "other side": local interpretations of adverse anti-malarial drug reactions in the Peruvian Amazon. Malar J. 2016; 15:136. PMC: 4774029. DOI: 10.1186/s12936-016-1193-x. View